PolyNovo Limited (ASX:PNV)
1.040
+0.010 (0.97%)
Aug 28, 2026, 4:10 PM AEST
PolyNovo Revenue
In the fiscal year ending June 30, 2026, PolyNovo had annual revenue of 149.85M AUD with 16.43% growth. PolyNovo had revenue of 79.52M in the half year ending June 30, 2026, with 41.89% growth.
Revenue
149.85M
Revenue Growth
+16.43%
P/S Ratio
4.79
Revenue / Employee
497.84K
Employees
301
Market Cap
718.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 149.85M | 21.15M | 16.43% |
| Jun 30, 2025 | 128.70M | 25.47M | 24.67% |
| Jun 30, 2024 | 103.23M | 37.56M | 57.20% |
| Jun 30, 2023 | 65.67M | 23.78M | 56.76% |
| Jun 30, 2022 | 41.89M | 12.55M | 42.78% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cochlear | 2.35B |
| SomnoMed | 118.50M |
| Saluda Medical | 114.04M |
| Aroa Biosurgery | 86.47M |
| Cyclopharm | 34.42M |
| Lumos Diagnostics Holdings | 19.07M |
| EBR Systems | 9.32M |
| EMVision Medical Devices | 8.85M |
PolyNovo News
- 2 days ago - PolyNovo Earnings Call Transcript: H2 2026 - Transcripts
- 2 days ago - PolyNovo Annual report: H2 2026 - Filings
- 2 days ago - PolyNovo Earnings release: H2 2026 - Filings
- 2 days ago - PolyNovo Slides: H2 2026 - Filings
- 5 weeks ago - PolyNovo Earnings release: Trading update - Filings
- 6 months ago - PolyNovo Earnings Call Transcript: H1 2026 - Transcripts
- 6 months ago - PolyNovo Quarterly report: H1 2026 - Filings
- 6 months ago - PolyNovo Slides: H1 2026 - Filings